新型冠状病毒肺炎合并肝损伤的发生机制

李璐; 李爽; 陈煜

doi:10.3969/j.issn.1001-5256.2021.01.046

新型冠状病毒肺炎合并肝损伤的发生机制

DOI: 10.3969/j.issn.1001-5256.2021.01.046

李璐^{1a, 2},
李爽^{1b, 2},
陈煜^{1a, 2,}

1a.
首都医科大学附属北京佑安医院肝病中心四科，北京 100069
1b.
首都医科大学附属北京佑安医院血液透析室，北京 100069
2.
肝衰竭与人工肝治疗研究北京市重点实验室，北京 100069

基金项目:

国家重点研发计划资助 (2017YFA0103000);

国家科技重大专项“艾滋病和病毒性肝炎等重大传染病防治” (2017ZX10203201-005);

北京市医院管理局临床医学发展专项经费资助 (ZYLX201806);

白求恩医学科学研究基金资助项目 (SG068FN)

作者贡献声明：李璐、李爽负责查阅文献；李璐负责撰写文章；陈煜负责指导撰写、修改文章，并最后定稿。

详细信息

作者简介:
李璐（1986—），女，主治医师，主要从事肝病研究

通信作者:
陈煜, chybeyond1071@ccmu.edu.cn

中图分类号: R575
计量
- 文章访问数: 1019
- HTML全文浏览量: 429
- PDF下载量: 41
- 被引次数: 0
出版历程
- 收稿日期: 2020-07-04
- 录用日期: 2020-07-30
- 出版日期: 2021-01-20

Pathogenesis of coronavirus disease 2019 with liver injury

Lu LI^{1a, 2},
Shuang LI^{1b, 2},
Yu CHEN^{1a, 2
,}

1a.
Hepatology Center Department 4, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China
1b.
Hemodialysis Room, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China
2.
Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research, Beijing 100069, China

摘要

摘要: 新型冠状病毒肺炎已对全球公共卫生造成了重大威胁。除呼吸系统外，部分患者可出现不同程度的肝损伤。基于相关文献，对病原学特征及其致病机制进行分析，初步探讨导致新型冠状病毒肺炎合并肝损伤出现的原因可能有病毒的直接作用、炎性细胞因子风暴、药物性肝损伤、低氧性肝损伤及免疫功能障碍等。建议临床可选择合理药物进行护肝治疗，减少肝损伤的发生。
- 新型冠状病毒肺炎 /
- 化学性与药物性肝损伤 /
- 治疗学
Abstract: Coronavirus disease 2019 (COVID-19) has become a major threat to global public health. In addition to injury in the respiratory system, some patients may have varying degrees of liver injury. With reference to related articles, this article analyzes the etiological characteristics and pathogenesis of COVID-19 and discusses the possible causes of COVID-19 with liver injury, including the direct effect of virus, inflammatory cytokine storm, drug-induced liver injury, hypoxic liver injury, and immune dysfunction. It is suggested that reasonable drugs should be selected in clinical practice to protect the liver and reduce the incidence rate of liver injury.
- Coronavirus Disease 2019 /
- Chemical and Drug Induced Liver Injury /
- Therapeutics

HTML全文

参考文献(31)

[1]	WANG C, HORBY PW, HAYDEN FG, et al. A novel coronavirus outbreak of global health concern[J]. Lancet, 2020, 395 (10223): 470-473. DOI: 10.1016/S0140-6736(20)30185-9
[2]	HORTON R. Offline: 2019-nCoV outbreak-early lessons[J]. Lancet, 2020, 395(10221): 322. DOI: 10.1016/S0140-6736(20)30212-9
[3]	LUO GG, GAO SJ. Global health concerns stirred by emerging viral infections[J]. J Med Virol, 2020, 92(4): 399-400. DOI: 10.1002/jmv.25683
[4]	CHEN N, ZHOU M, DONG X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study[J]. Lancet, 2020, 395(10223): 507-513. DOI: 10.1016/S0140-6736(20)30211-7
[5]	WANG D, HU B, HU C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China[J]. JAMA, 2020, 323(11): 1061-1069. DOI: 10.1001/jama.2020.1585
[6]	HUANG C, WANG Y, LI X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet, 2020, 395(10223): 497-506. DOI: 10.1016/S0140-6736(20)30183-5
[7]	LAI MM, CAVANAGH D. The molecular biology of coronaviruses[J]. Adv Virus Res, 1997, 48: 1-100.
[8]	ADAMS MJ, CARSTENS EB. Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2012)[J]. Arch Virol, 2012, 157(7): 1411-1422. DOI: 10.1007/s00705-012-1299-6
[9]	ZHOU P, YANG XL, WANG XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin[J]. Nature, 2020, 579(7798): 270-273. DOI: 10.1038/s41586-020-2012-7
[10]	WHO. WHO Director-General's remarks at the media briefing on 2019-nCoV on 11st February 2020[R]. Geneva: WHO, 2020.
[11]	LI F. Structure, function, and evolution of coronavirus spike proteins[J]. Annu Rev Virol, 2016, 3(1): 237-261. DOI: 10.1146/annurev-virology-110615-042301
[12]	LU G, WANG Q, GAO GF. Bat-to-human: Spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond[J]. Trends Microbiol, 2015, 23(8): 468-478. DOI: 10.1016/j.tim.2015.06.003
[13]	WANG Q, WONG G, LU G, et al. MERS-CoV spike protein: Targets for vaccines and therapeutics[J]. Antiviral Res, 2016, 133: 165-177. DOI: 10.1016/j.antiviral.2016.07.015
[14]	BRADFORD CN, ELY DR, RAIZADA MK. Targeting the vasoprotective axis of the renin-angiotensin system: A novel strategic approach to pulmonary hypertensive therapy[J]. Curr Hypertens Rep, 2010, 12(4): 212-219. DOI: 10.1007/s11906-010-0122-6
[15]	CHAI XQ, HU L, ZHANG Y, et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCov infection[J]. bioRxiv, 2020.[Online ahead of print] http://www.researchgate.net/publication/340003305_Recapitulation_of_SARS-CoV-2_Infection_and_Cholangiocyte_Damage_with_Human_Liver_Organoids
[16]	SUN C, FAN JG. Strengthen clinical research on liver injury in patients with novel corona virus pneumonia[J]. J Prac Hepatol, 2020, 23(2): 153-155. (in Chinese) DOI: 10.3969/j.issn.1672-5069.2020.02.001 孙超, 范建高. 加强新型冠状病毒肺炎患者肝损伤的临床研究[J]. 实用肝脏病杂志, 2020, 23(2): 153-155. DOI: 10.3969/j.issn.1672-5069.2020.02.001
[17]	BERTOLINI A, van de PEPPEL IP, BODEWES FAJA, et al. Abnormal liver function tests in patients with Covid-19: Relevance and potential pathogenesis[J]. Hepatology, 2020, 72(5): 1864-1872. DOI: 10.1002/hep.31480
[18]	CHANNAPPANAVAR R, PERLMAN S. Pathogenic human coronavirus infections: Causes and consequences of cytokine storm and immunopathology[J]. Semin Immunopathol, 2017, 39(5): 529-539. DOI: 10.1007/s00281-017-0629-x
[19]	XU XW, WU XX, JIANG XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: Retrospective case series[J]. BMJ, 2020, 368: m606. http://www.researchgate.net/publication/341503517_Clinical_Characteristics_of_Patients_Infected_With_the_Novel_2019_Coronavirus_SARS-Cov-2_in_Guangzhou_China
[20]	FAN Z, CHEN L, LI J, et al. Clinical features of COVID-19-related liver functional abnormality[J]. Clin Gastroenterol Hepatol, 2020, 18(7): 1561-1566. DOI: 10.1016/j.cgh.2020.04.002
[21]	CHEN P, ZHOU B. Clinical characteristics of COVID-19 patients with abnormal liver tests[J]. J Hepatol, 2020, 73(3): 712-713. DOI: 10.1016/j.jhep.2020.04.028
[22]	XUAN ZX, ZHANG GB, YE X, et al. Cause analysis of liver injury in patients infected by novel coronavirus and suggestion of drug monitoring[J]. Chin Pharmacol Bull, 2020, 36(4): 19-20. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-YAOL202004026.htm 宣自学, 张国兵, 叶晓, 等. 新型冠状病毒肺炎患者肝损的原因分析[J]. 中国药理学通报, 2020, 36(4): 19-20. https://www.cnki.com.cn/Article/CJFDTOTAL-YAOL202004026.htm
[23]	BASTURK A, ARTAN R, YILMAZ A, et al. Acute vanishing bile duct syndrome after the use of ibuprofen[J]. Arab J Gastroenterol, 2016, 17(3): 137-139. DOI: 10.1016/j.ajg.2016.08.006
[24]	CHALASANI N, BONKOVSKY HL, FONTANA R, et al. Features and outcomes of 899 patients with drug-induced liver injury: The DILIN prospective study[J]. Gastroenterology, 2015, 148(7): 1340-1352. DOI: 10.1053/j.gastro.2015.03.006
[25]	HENRION J. Hypoxic hepatitis[J]. Liver Int, 2012, 32(7): 1039-1052. DOI: 10.1111/j.1478-3231.2011.02655.x
[26]	BANGASH MN, PATEL J, PAREKH D. COVID-19 and the liver: Little cause for concern[J]. Lancet Gastroenterol Hepatol, 2020, 5(6): 529-530. DOI: 10.1016/S2468-1253(20)30084-4
[27]	ADAMS DH, HUBSCHER SG. Systemic viral infections and collateral damage in the liver[J]. Am J Pathol, 2006, 168(4): 1057-1059. DOI: 10.2353/ajpath.2006.051296
[28]	YUEN KY, WONG SS. Human infection by avian influenza A H5N1[J]. Hong Kong Med J, 2005, 11(3): 189-199. http://femspd.oxfordjournals.org/lookup/external-ref?access_num=16192482&link_type=MED&atom=%2Ffemspd%2F71%2F2%2F94.atom
[29]	NARASARAJU T, YANG E, SAMY RP, et al. Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis[J]. Am J Pathol, 2011, 179(1): 199-210. DOI: 10.1016/j.ajpath.2011.03.013
[30]	QIAN ZP, MEI X, ZHANG YY, et al. Baseline biochemical markers of novel coronavirus pneumonia in Shanghai area: Analysis of 324 cases[J]. Chin J Hepatol, 2020, 28(3): 229-233. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-SYIY2020S1056.htm 钱志平, 梅雪, 张宇一, 等. 上海地区324例新型冠状病毒肺炎患者基线肝功能分析[J]. 中华肝脏病杂志, 2020, 28(3): 229-233. https://www.cnki.com.cn/Article/CJFDTOTAL-SYIY2020S1056.htm
[31]	China Digestion Association, Chinese Medical Doctor Association; Chinese Society of Hepatology, Chinese Medical Association. The protocol for prevention, diagnosis and treatment of liver injury in coronavirus disease 2019[J]. J Clin Hepatol, 2020, 36(4): 754-757. (in Chinese) DOI: 10.3969/j.issn.1001-5256.2020.04.008 中国医师协会消化医师分会, 中华医学会肝病学分会. 新型冠状病毒肺炎合并肝脏损伤的预防及诊疗方案[J]. 临床肝胆病杂志, 2020, 36(4): 754-757. DOI: 10.3969/j.issn.1001-5256.2020.04.008